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Homoeopathic treatment of a diabetic COVID-19 patient with the complication of
bronchitis and pleural effusion - A case report
Abstract
Introduction
Introduction: COVID-19 is a novel SARS-CoV-2 disease that has caused a worldwide pandemic. It is highly
contagious and produces severe acute respiratory syndrome. Many homoeopathic medicines have been
suggested for treatment of COVID cases and reports have also been published. Case Summary: The
present case report is of a 61-year-old COVID-positive, male, presenting with complications such as
bronchitis and pleural effusion. He was treated for COVID-19 with a suitable homoeopathic medicine,
based on the totality of symptoms, while the patient continued his regular regime of conventional
medicine for diabetes mellitus and hypertension. The indicated remedy led to immediate relief of the
symptoms, especially chest pain, along with a marked improvement in the laboratory investigations. The
Modified Naranjo Criteria score after treatment was 8, which explicitly shows the positive causal
attribution of the individualised homoeopathic medicine, Phosphorus, in this case. Homoeopathic
treatment has shown favourable results in this case and demonstrates the scope of Homoeopathy in
infectious cases.
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Introduction
COVID-19 is a highly contagious viral illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Standard treatment is yet to be discovered by the conventional
system for this illness. The most common pharmacological
interventions used are antivirals, dexamethasone, monoclonal
antibodies, etc. These therapies are highly targeted and focus
on reducing viral load.[1] Reverse transcription-polymerase
chain reaction RT-PCR or computed tomography (CT) scan
of the chest are done to diagnose this infection.[2,3] Pneumonia
and pleural effusion are among the recognised complications
of COVID-19.[4]
India reported its first case of COVID-19 on 30 January
2020. This rose to three cases by February 3, 2020. No
further cases were reported in February 2020. However,
by mid-March, the number of infected cases started to
increase and many cases were reported from all over India.
The first COVID-19-related death in India was reported on
March 12, 2020. Till 22 February 2022, there have been
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418,650,474 confirmed cases and 5,856,224 deaths globally
and 42,838,524 cases and 512,141 deaths in India. [5,6]
Homoeopathic literature enlists many medicines for COVID
19 such as Arsenicum album, Bryonia alba, Gelsemium
sempervirens and Pulsatilla nigricans from a prognostic
factor research.[7]
A case report of COVID-19 complicated with pleural effusion
and bronchitis successfully treated with homoeopathic
medicine Phosphorus is presented here. This case has
been reported according to the Hom-Case extension to the
CARE clinical case reporting guideline and highlights the
effectiveness of homoeopathy for the treatment of COVID 19
and its associated conditions, following the basic principles
of homoeopathy.[8]
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Patient Information

Clinical findings

A 61-year-old diabetic male patient presented with cough and
chest pain in the lower left lateral side, with shortness of breath
for 4 days at the time of the visit. The patient could not sleep
and had to sit up at night to breathe. Previously, the patient was
admitted to a rural hospital but the chest pain and respiratory
discomfort continued and the attendants decided to shift him
to another super speciality hospital. However, that could not
be done due to the non-availability of a bed, and ultimately,
the patient returned home, where he took treatment in isolation
and consulted us on 15 January 2022.
The patient reported pain on the left lower side of the chest
since 9 January 2022, which aggravated on lying on the
left side, on the back and at night. There was a catching
pain on deep breathing with shortness of breath. His cough
had rusty sputum. The patient was suffering from type 2
diabetes for 12 years and he was under medication for
diabetes and hypertension and was taking conventional
medicines for the same. As the patient party searched many
hospitals for admission but there were no beds available
in the hospitals, so the patient had to be treated at home
in isolation.[9,10]
The patient had a poor appetite and nausea, with loathing of
food and normal thirst. He also complained of tastelessness
and acuteness of smell with intolerance of the smell of cooking
food. His sleep was disturbed due to chest pain and he could
not breathe properly while lying. His stool was offensive. On
enquiring, it was informed that when his complaints began, he
had profuse sweat and episodes of bedwetting.

Mental generals

The patient was cooperative and very talkative. Although
excess talking exhausted him, he narrated his complaints in
detail. During illness, he was afraid of being alone and wanted
his family members to be present by his side all the time. He
was anxious about his illness. He was interpreted to be of
jealous nature since he expressed his jealousy towards his
brothers for property possessions. He said he was not satisfied
with the distribution of family property by his father, which
had occurred a long time ago.
The patient did not suffer from any other major illness in the
past, except type 2 diabetes mellitus, for which he was under
medication. Family history was not significant.

There was a pain in the left lower side of the chest, which was
aggravated by lying on the affected side and on the back. On
examination, a catching pain in the chest during deep breathing
was noted. His blood pressure was normal, pulse rate 86/min
and respiratory rate was 22/min. The patient was afebrile at
the time of the visit and weighed 68 kg. Oxygen saturation was
also normal. ECG done for left-sided chest pain, just before
discharge from the previous rural hospital, was found normal.

Diagnostic assessment

The patient was already diagnosed with COVID-19 infection
through RT-PCR on 11 January 2022 and we advised some
laboratory investigations to know the present status. The
readings are summarised in Table 1. The Spo2 was normal
and so oxygen support was not required at the moment. The
patient was, however, also advised to continue searching for a
hospital bed and consult a conventional medicine practitioner.
Meanwhile, though, the patient was kept under isolation along
with the homoeopathic medication.[11]

Therapeutic intervention

A detailed case-taking was done as per Hahnemannian guidelines
laid out in the Organon of Medicine, followed by analysis and
evaluation of the symptoms.[12] The totality of symptoms was
selected. The left-sided pain in the chest aggravated after
sleeping and the patient was very loquacious and jealous in
nature. Based on these symptoms, Lachesis mutens 0/1 BD was
prescribed for 3 days on 15 January 2022. There was, however,
no improvement after taking Lachesis in the next 3 days.
The case was then re-investigated and it was found that the
chest pain was aggravated after lying in bed and not after
sleep. The repertorisation was done taking into account only
the most striking mental generals, physical generals and
uncommon particulars using Dr James Tyler Kent’s repertory.
Repertorisation result is shown in Figure 1. The following
symptoms were considered for repertorisation:
1. Company desire for
2. Acuteness of smell
3. Profuse sweat at night
4. Stool offensive
5. Pleural effusion left side
6. Chest pain left side
7. Chest pain aggravates on lying on the left side, on the
painful side

Table 1: Summary of investigation reports
Investigations Before treatment

After treatment

D‑dimer
CRP
Ferritin
TLC
LDH
HRCT Thorax

2.09 ng FEU/mL (upto 500 ng FEU/mL)
17.64 mg/L (<5 mg/L)
244 ng/mL (22–322 ng/mL)
8.3 × 103/uL (4–10)
218 U/L (120–246)
No pleural effusion. Very low CT severity score 3/40 Figure 4
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1151 ng FEU/mL (up to 500 ng FEU/mL)
83.74 mg/L (<5 mg/L)
692.5 ng/mL (22–322 ng/mL)
10.69 × 103/uL (4–10)
307 U/L (120‑246)
Focal consolidation seen in left lower lobe. Bronchitis. Left pleural
effusion. Figure 3 (CT severity score was not mentioned in the report)
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8. Chest pain aggravates lying on back
9. Rusty expectoration.
After repertorisation, Phosphorus 30°C was prescribed
upon final consultation with Materia Medica.[13] As the case
was acute and symptoms were very intense and striking,
Phosphorus was selected as the best similimum to the case.
One dose of the medicine was given for 2 days.

Follow-up and outcome

Following the remedy, there was a marked improvement on
the very 1st day and the patient was able to sleep comfortably
from the 2nd day onward, after a long time. Date-wise followups with results of investigations are summarised in Tables 1
and 2. Figure 2 gives the timeline of the case.
In this case, the total score of outcomes, as per Modified
Naranjo Criteria was 9, which is close to the total score
of 13 and explicitly shows the positive causal attribution
of the individualised homoeopathic medicine, phosphorus
[Table 3].[14]
Improvement started immediately after medicine of appropriate
potency was given to the patient. The patient reported overall
relief in signs and symptoms, such as chest pain, lying on
the left side, the acuteness of smell and improved appetite.

Marked improvement in the laboratory investigation reports
of 22 January 2022 and HRCT Chest done on 2 February 2022
also confirmed the same. No adverse event was reported during
the course of treatment.

Discussion
Homoeopathy is a system of medicine which embraces a
holistic approach to the treatment of a diseased person. In
homoeopathy, detailed case-taking is done to draw a totality
of symptoms and a single remedy is selected on the basis of
the totality of symptoms.
The spectrum of COVID-19 symptoms is broad, ranging
from a mild, self-limiting respiratory tract illness to severe
progressive pneumonia, multi-organ failure and possible
death. Despite many efforts and multiple clinical trials,
there are, to date, no specific therapeutic agents to treat or
cure the coronavirus infection. A case series of five patients
with moderate to severe COVID-19 infections, 2 of them
hospitalised in the intensive care unit and successfully treated
with homoeopathy, has been reported. All five patients
responded to homoeopathic treatment in an unexpectedly
short time span, improving both physically and mentally.[15] A
randomised, placebo-controlled trial of adjunct homoeopathy

Figure 1: Reportorial sheet
Symptoms
• Presenting symptoms were taken with
modalities
• Medicine prescribed on the basis of
keynote symptoms.
• Lachesis 0/1, 6 doses prescribed
BD x 3 days

• No change in any symptom.
• re-case taking done
• Phosphorus 30/2 doses prescribed
The patient improved within 2 days
of taking phosphorus 30
Chest pain ameliorated and the
patient could lie comfortably
The patient was advised to
repeat the investigations

Investigations
15/01/2022

11/01/22- RT-PCR +ve
D-dimer -1151 ngFEU/ml
CRP – 83.74 mg/L
Ferritin – 692.5 ng/ml
LDH- 307 U/L
HRCT- Left pleural effusion

18/01/2022

20/01/2022
22/02/2022

22/01/22- RT-PCR -ve
D-dimer – 2.09ngFEU/ml
CRP- 17.64 mg/L
HRCT- No pleural effusion

Figure 2: Timeline
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Table 2: Follow‑up and outcomes
Date

Indication for prescription

Medicine with dose and repetition

15 January 2022

Left‑sided chest pain
Chest pain aggravates on sleeping
Loquacious, jealous.
No relief. Left‑sided chest pain
<Lying on the painful side, left
<Lying on back
Rusty sputum
The patient can lie comfortably
The patient was much better

Lachesis 0/1, 6 doses BD×3 days

18 January 2022

20 January 2022
24 January 2022

04 February 2022 No more discomfort

Justification

Lt‑sided chest affection
Pt could not sleep at night
Loquacity, jealous
Phosphorus 30°C, 2 doses OD for 2 days Left‑sided pleural effusion
Can’t lie on the left [affected] side, as well as on the back.
Company desire for, catching pain during deep breathing.
Very rapid improvement noticed after Phosphorus30
The patient improved very much. The reports of 22
January 2022 within normal
The patient is much better. HRCT report shows no
effusion.

Placebo
Placebo
Placebo

Table 3: Assessment by Modified Naranjo criteria score
Item

Yes No Not sure/NA

1. Was there an improvement in the main symptom or condition for which the homoeopathic medicine was prescribed?
2. Did the clinical improvement occur within a plausible time frame relative to the medicine intake?
3. Was there a homeopathic aggravation of symptoms?
4. Did the effect encompass more than the main symptom or condition (i.e., were other symptoms, not related to the main
presenting complaint, improved or changed?
5. Did overall well‑being improve?
6. A. Direction of cure: Did some symptoms improve in the opposite order of the development of symptoms of the disease?
7. B. Direction of cure: Did at least one of the following aspects apply to the order of improvement of symptoms:
• From organs of more importance to those of less importance?
• From deeper to more superficial aspects of the individual?
• From the top downwards?
8. Did old symptoms (defined as non‑seasonal and non‑cyclical that were previously thought to have resolved) reappear
temporarily during the course of improvement?
9. Are there alternative causes (i.e., other than the medicine) that with a high probability ‑ could have caused the improvement?
(consider known course of disease, other forms of treatment and other clinically relevant intervention)
10. Was the health improvement confirmed by any objective evidence? (e.g., investigations and clinical examination)
11. Did repeat dosing, if conducted, create similar clinical improvement?
Total

+2
+1

Figure 3: HRCT dated 11 January 2022 (arrow showing the lower margin
of the left lung is not clear due to pleural effusion)

with the standard of care for COVID-19 was conducted on
300 patients, which significantly favoured the use of standard
of care and homoeopathy. A. album and Phosphorus were the
most frequently prescribed medicines.[16] There is another case
report on individualised homoeopathic treatment in a case of
severe acute thromboinflammation in a COVID 19 patient in
304

0
+1
+2
0
0

0
0
+2
0
8

Figure 4: HRCT dated 02 February 2022 (arrow showing clear lower
margin of the left lung)

which the inflammatory parameters improved dramatically
within the first 12 h and complete resolution was demonstrated
after 10 days.[17] This case report is an evidence of how the
use of homoeopathy right from the beginning of a disease can
help even in a serious clinical condition. In the present case,
initially, the symptoms of the patient were misinterpreted as the
aggravation of lying was misinterpreted as aggravation from
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sleep. Therefore, the selected remedy, Lachesis, gave no relief
to the patient. But when the symptoms were verified again, then
the most similar remedy turned out to be Phosphorus, which
brought immediate relief to the patient. This individualised
approach in the treatment of COVID 19, backed with all the
laboratory reports in support of the successful treatment has
shown favourable results and undoubtedly thrown some light
on the scope of homoeopathy in such virulent conditions. The
outcome of interest, in this case, was a rapid improvement of
the patient’s condition which was evident from the HRCT
reports, along with the reduction in other inflammatory markers
and possibly a prevention of other associated complications.
Controlled studies, with long-term follow-ups and large sample
sizes, are required for validation of these results.

3.
4.
5.
6.
7.
8.
9.

Patient perspective

The patient said that after 11 days of intense suffering, he could
now lie comfortably on his back and sleep well.

10.

Informed consent

A written informed consent was obtained from the patient for
reporting this case.

11.

Conclusion

12.

This case shows the positive response of individualized
homoeopathic treatment in a complicated case of covid 19
within a short span of time along with the marked improvement
of laboratory parameters. This may suggest that in future,
homoeopathic treatments can be given preference for such
infectious viral diseases under careful observation of a
homoeopathic physician.
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Traitement homéopathique d'un patient diabétique Covid-19 avec une complication de bronchite et d'épanchement
pleural: un rapport de cas.
Introduction: Le COVID-19 est un nouveau SARS-CoV-2 qui a provoqué une pandémie mondiale. Elle est hautement contagieuse
et produit un syndrome respiratoire aigu sévère. De nombreux médicaments homéopathiques ont été proposés pour le traitement
des cas de covid et des rapports ont également été publiés.. Résumé du cas: Le présent rapport concerne un homme de 61 ans,
Covid-positif, présentant des complications telles que bronchite et épanchement pleural. Il a été traité pour le COVID-19 avec
un médicament homéopathique approprié, basé sur la totalité des symptômes, tandis que le patient a continué son régime régulier
de médecine conventionnelle pour le diabète sucré et l'hypertension. Le remède indiqué a entraîné un soulagement immédiat
des symptômes, notamment des douleurs thoraciques, ainsi qu'une nette amélioration des examens de laboratoire. Le score du
critère modifié de Naranjo après traitement était de 8, ce qui montre explicitement l'attribution causale positive du médicament
homéopathique individualisé, Phosphorus, dans ce cas. Le traitement homéopathique a donné des résultats favorables dans ce
cas et démontre la portée de l'homéopathie dans les cas infectieux..
Homöopathische Behandlung eines diabetischen Covid-19-Patienten mit der Komplikation einer Bronchitis und eines
Pleuraergusses: Ein Fallbericht
Einleitung: COVID-19 ist eine neuartige SARS-CoV-2-Erkrankung, die eine weltweite Pandemie ausgelöst hat. Sie ist hoch
ansteckend und verursacht ein schweres akutes Atemwegssyndrom. Viele homöopathische Arzneimittel wurden für die Behandlung
von Covid-Fällen vorgeschlagen, und es wurden auch Berichte veröffentlicht. Zusammenfassung des Falls: Der vorliegende
Fallbericht handelt von einem 61-jährigen Covid-positiven Mann, der Komplikationen wie Bronchitis und Pleuraerguss
aufwies. Er wurde auf der Grundlage der Gesamtheit der Symptome mit einem geeigneten homöopathischen Arzneimittel auf
COVID-19 behandelt, während der Patient seine reguläre Behandlung mit konventionellen Medikamenten gegen Diabetes
mellitus und Bluthochdruck fortsetzte. Das indizierte Mittel führte zu einer sofortigen Linderung der Symptome, insbesondere
der Brustschmerzen, sowie zu einer deutlichen Verbesserung der Laboruntersuchungen. Der modifizierte Naranjo-Kriterien-Score
nach der Behandlung betrug 8, was die positive kausale Zuordnung des individualisierten homöopathischen Mittels Phosphorus
in diesem Fall eindeutig belegt. Die homöopathische Behandlung hat in diesem Fall günstige Ergebnisse gezeigt und demonstriert
den Anwendungsbereich der Homöopathie bei Infektionskrankheiten..
श्वसनीशोध (ब्रोंक�ाइटिस) और प्लूरल एफ्फुजन की जटिलता के साथ एक मधुमेह कोविड-19 रोगी का होम्योपैथिक उपचार: एक
विषय रिपोर्ट
परिचय: कोविड -19 एक नॉवल एसएआरएस-सीओवी-2 S बीमारी है जोकि दु निया भर में महामारी का कारण बना है । यह अत्यधिक
संक्रामक है और गंभीर तीव्र श्वसन सिंड्रोम पैदा करता है । कोविड मामलों के इलाज के लिए कई होम्योपैथिक दवाओं का सुझाव दिया गया है
और भी प्रकाशित की गई हैं । विषय सारांश: वर्तमान केस रिपोर्ट एक 61 वर्षीय कोविड-पॉजिटिव पुरुष की है , जो श्वसनीशोध (ब्रोंक�ाइटिस)
प्लूरल एफ्फुजन जैसी जटिलताओं को प्रस्तुत करता है । लक्षणों की समग्रता के आधार पर, एक उपयुक्त होम्योपैथिक दवा के साथ उनका
इलाज कोविड -19 के लिए किया गया, और रोगी ने मधुमेह और उच्च रक्तचाप के लिए पारं परिक दवा का अपना नियमित उपचार जारी
रखा। संकेतित उपाय से लक्षणों में तत्काल राहत मिली, विशेष रूप से सीने में दर्द के साथ-साथ प्रयोगशाला जां च में उल्लेखनीय सुधार हुआ।
उपचार के बाद संशोधित नारं जो मानदं ड स्कोर 8 था, जो इस मामले में व्यक्तिगत होम्योपैथिक दवा, फास्फोरस के सकारात्मक कारण को
स्पष्ट रूप से दर्शाता है । होम्योपैथिक उपचार ने इस मामले में अनुकूल परिणाम दिखाए हैं जो संक्रामक मामलों में होम्योपैथी के दायरे को
प्रदर्शित करता है ।
Tratamiento homeopático de un paciente diabético Covid-19 con complicación de bronquitis y derrame pleural: Reporte
de un caso
Introducción: COVID-19 es una nueva enfermedad del SRAS-CoV-2 que ha causado una pandemia mundial. Es altamente
contagiosa y produce síndrome respiratorio agudo severo. Se han sugerido muchos medicamentos homeopáticos para el
tratamiento de los casos covid y también se han publicado informes. Resumen del caso: El presente caso clínico es de un varón
Covid positivo de 61 años, con complicaciones como bronquitis y derrame pleural. Fue tratado por COVID-19 con una medicina
homeopática adecuada, basada en la totalidad de los síntomas, mientras que el paciente continuó su régimen regular de medicina
convencional para la diabetes mellitus y la hipertensión. El remedio indicado condujo al alivio inmediato de los síntomas,
especialmente el dolor torácico, junto con una notable mejoría en las investigaciones de laboratorio. La puntuación modificada
de los criterios de Naranjo después del tratamiento fue de 8, lo que muestra explícitamente la atribución causal positiva de la
medicina homeopática individualizada, el Fósforo, en este caso. El tratamiento homeopático ha mostrado resultados favorables
en este caso y demuestra el alcance de la homeopatía en casos infecciosos.
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糖尿病患者的同济疗法治疗科维德-19支气管炎和胸腔积液并发症的患者: 一个案例报告
简介: 科维德-19是一种新的萨尔斯 -科维德 2 引起全球大流行的疾病。它具有高度传染性，并产生严重的急性呼
吸道综合征。. 许多顺势疗法药物被建议用于治疗科维德病例，也有报告发表。. 案件摘要: 本病例报告的是一位
61岁的科维德-患有阳性的男性，出现了支气管炎和胸腔积液等并发症。他接受了以下治疗科维德-19根据全部症状，
使用合适的同种疗法药物，同时病人继续服用治疗糖尿病和高血压的常规药物。. 指明的药方使症状立即得到缓解，
特别是胸痛，同时实验室检查也有明显改善。. 治疗后的修正纳兰霍标准得分是8分，这明确显示了个体化的同位素
药物--磷在本病例中的积极因果关系。. 顺势疗法在这个案例中显示了有利的结果，并证明了顺势疗法在感染性案
例中的应用范围。.
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